0001415889-24-004183.txt : 20240216
0001415889-24-004183.hdr.sgml : 20240216
20240216173934
ACCESSION NUMBER: 0001415889-24-004183
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Torley Helen
CENTRAL INDEX KEY: 0001528185
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32335
FILM NUMBER: 24649791
MAIL ADDRESS:
STREET 1: C/O ONYX PHARMACEUTICALS, INC.
STREET 2: 249 EAST GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001159036
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 880488686
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12390 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 794-8889
MAIL ADDRESS:
STREET 1: 12390 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC
DATE OF NAME CHANGE: 20040312
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC
DATE OF NAME CHANGE: 20010912
4
1
form4-02162024_100226.xml
X0508
4
2024-02-15
0001159036
HALOZYME THERAPEUTICS, INC.
HALO
0001528185
Torley Helen
C/O HALOZYME THERAPEUTICS, INC.
12390 EL CAMINO REAL
SAN DIEGO
CA
92130
true
true
false
false
PRESIDENT AND CEO
0
Common Stock
2024-02-15
4
M
0
13092
0
A
651096
D
Common Stock
2024-02-15
4
F
0
7036
35.91
D
644060
D
Common Stock
2024-02-15
4
A
0
32781
0
A
676841
D
Common Stock
2024-02-15
4
F
0
17619
35.91
D
659222
D
Restricted Stock Units
0
2024-02-15
4
M
0
13092
0
D
Common Stock
13092
13092
D
The reported disposition of 7,036 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer.
The reported disposition of 17,619 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
/s/ James R. Oehler, Attorney-in-Fact
2024-02-16